Is Evelo Biosciences Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: EVLO) stock is to Hold EVLO stock.
Out of 1 analyst, 0 (0%) are recommending EVLO as a Strong Buy, 0 (0%) are recommending EVLO as a Buy, 1 (100%) are recommending EVLO as a Hold, 0 (0%) are recommending EVLO as a Sell, and 0 (0%) are recommending EVLO as a Strong Sell.
What is EVLO's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: EVLO) forecast ROE is N/A, which is considered weak.
What is EVLO's Price Target?
According to 1 Wall Street analyst that have issued a 1 year EVLO price target, the average EVLO price target is $10.00, with the highest EVLO stock price forecast at $10.00 and the lowest EVLO stock price forecast at $10.00.
The Wall Street analyst predicted that Evelo Biosciences's share price could reach $10.00 by Jul 26, 2024. The average Evelo Biosciences stock price prediction forecasts a potential upside of 2,339.02% from the current EVLO share price of $0.41.
What is EVLO's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: EVLO) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.13%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.